Cml Healthcare Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

CLC 0.0000
price chart
Cipher Pharmaceuticals has multiple ways to create shareholder value, says ...
Mississauga-based Cipher Pharmaceuticals is a spinoff of CML Healthcare, a more than three-decades old medical imaging company that shed its drug development division, which was burning cash, when it decided to convert to an income trust.
Doctor charged after woman touched inappropriately, police say
Correction - October 24, 2014: This article was edited from a previous version that misstated the name of the clinic that the doctor worked at as the CML Healthcare Clinic. In fact, CML HealthCare is a medical laboratory and does not employ physicans.
Toronto doctor faces charges in sexual assault investigation  The Toronto Observer
Toronto doctor charged with sexual assault, harassment  MetroNews Canada
Related articles »  
52 Year Old Toronto Dr Charged With Sexual Assault on 26 Year Old Patient ...
tps DR oct 24 2014 The Toronto Police Service would like to make the public aware of an arrest in a Sexual Assault investigation. During spring 2013, a woman, 26, attended the CML Healthcare Clinic at 688 Coxwell Avenue, for a routine medical ...
Related articles »  
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for ...
�The authorized indications and the favorable benefit-risk balance of Iclusig give healthcare providers the ability to optimize the use of Iclusig in patients with resistant or intolerant CML.� ... Iclusig� is a registered trademark of ARIAD ...
ARIAD Pharma (ARIA) Updates on Final Recommendation by CHMP for Iclusig (subscription)
Related articles »  
Microchip makers wired for growth
(TMZ), which provides low-power wireless microchips to the digital radio, connected audio and wireless healthcare markets. One of its ... (CML) makes microchips for the storage and wireless communication markets, both of which have weakened recently.
Related articles »  
Ariad Pharma: Will It Return To Its Heyday?
( - Shares of Ariad Pharmaceuticals Inc. ( ARIA ) have gained more than 60 percent in the last one year, and it looks like the company is slowly getting back in the game.
EMA's CHMP adopts final opinion on ARIAD Pharmaceuticals' Iclusig ...
EMA recommends further measures to minimise risk of blood vessel blockage ...
Related articles »  
Slippery Slope Guide to Surrogate Approvals
azacitidine (Vidaza), $4,808, Myelodysplastic Syndrome (MDS), Chronic Myeloid Leukemia (CML), 2004, Surrogate, Overall Response Rate (ORR), Pharmion.
corporate corner
LAHORE (PR): Building on the recent success at Cannes, BBDO Pakistan roared once again at the biggest Lions festival in the region, Spikes Asia 2014, by winning 10 awards for their �Not a bug splat' campaign across design, direct, media, outdoor and ...
Novartis: Continued Operating Strength, Shares Fairly Valued
Current growth products, such as gilenya (an oral treatment for multiple sclerosis), Tasigna (an oral tyrosine kinase inhibitor for CML) and Jakavi (an oral JAK-inhibitor for myelofibrosis) all showed double-digit growth in sales as well. Perhaps the ...
Related articles »  
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog
Late last week, ARIAD Pharmaceuticals Inc. ( ARIA ) announced that PRAC provided a positive risk/benefit assessment following the completion of review of Iclusig under the Article 20 referral procedure.
Europe's Rx Risk Assessment Group Recommends Keeping Iclusig Indications ...  GenomeWeb
ARIADs Iclusig Gains Positive Recommendation from PRAC
Related articles »